This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, M.-Y. Articles by Lu, L.-J. W. Search for Related Content PubMed PubMed Citation Articles by Wang, M.-Y. Articles by Lu, L.-J. W.

Differential Effect of Gestation Stage on Benzo(a)pyrene-induced Micronucleus Formation and/or Covalent DNA Modifications in Mice¹

Department of Preventive Medicine and Community Health, The University of Texas Medical Branch, Galveston, Texas 77550

Benzo(a)pyrene (BP), an environmental carcinogen, binds ubiquitously to the DNA of maternal and fetal tissues (Lu et al., Cancer Res., 46: 3046–3054, 1986). These studies further investigated the effect of gestation age on the induction of genetic damage by BP. Timed-pregnant ICR mice were treated with one dose of BP on various days of gestation and sacrificed 24–120 h after treatment. At the molecular level, BP covalently bound to the DNA of adult bone marrow and fetal liver of mice at all gestation ages. Compared to the nonpregnant mice (adduct level = 15 adducts/10⁸ bases), the adduct levels in the pregnant adult bone marrow were decreased up to 50% during early gestation (days 3–9) and then increased steadily to a 4-fold excess over nonpregnant values during late gestation (days 15–18). In the fetal liver, adduct levels exhibited little variation (3–4 adducts/10⁸ bases) between days 11 and 15 of gestation and then increased sharply to 14 adducts/10⁸ bases after day 16. At the cellular level, a higher percentage of polychromatic RBCs from adult and fetal mice after BP treatment contained micronuclei (MN) than controls (solvent or untreated). Bone marrow from pregnant mice exhibited greater increases in the formation of MN during early gestation (days 3–9) relative to late gestation (days 15–18), compared to the nonpregnant mice. In the fetuses, the amounts of MN formed were higher than those found in the adult nonpregnant or maternal mice, but these amounts decreased with gestation progression. Thus, MN induction with gestation progression differed from DNA adduction in adults and fetuses. In addition, the dose and time responses of MN formation also differed from those of covalent DNA modifications, when analyzed in the bone marrow of pregnant mice treated on gestation day 5. Collectively, our results showed that pregnancy and development modulate different types of genetic damage in different ways. Fetal tissues may be more sensitive than maternal tissues to genetic damage. Factors in addition to DNA adduct formation may be responsible for MN induction.

¹ Supported by USPHS Grant CA 44163.

² To whom requests for reprints should be addressed, at Department of Preventive Medicine and Community Health, The University of Texas Medical Branch, 24 Keiller, F-19, Galveston, TX 77550.

Received 3/31/89. Revised 12/ 7/89.

This article has been cited by other articles:

				S. Wang, S. Chanock, D. Tang, Z. Li, W. Jedrychowski, and F. P. Perera Assessment of Interactions between PAH Exposure and Genetic Polymorphisms on PAH-DNA Adducts in African American, Dominican, and Caucasian Mothers and Newborns Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 405 - 413. [Abstract] [Full Text] [PDF]

				F. Perera, D. Tang, R. Whyatt, S. A. Lederman, and W. Jedrychowski DNA Damage from Polycyclic Aromatic Hydrocarbons Measured by Benzo[a]pyrene-DNA Adducts in Mothers and Newborns from Northern Manhattan, The World Trade Center Area, Poland, and China Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 709 - 714. [Abstract] [Full Text] [PDF]

				R. M. Whyatt, W. Jedrychowski, K. Hemminki, R. M. Santella, W.-Y. Tsai, K. Yang, and F. P. Perera Biomarkers of Polycyclic Aromatic Hydrocarbon-DNA Damage and Cigarette Smoke Exposures in Paired Maternal and Newborn Blood Samples as a Measure of Differential Susceptibility Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 581 - 588. [Abstract] [Full Text] [PDF]